January 2019

Michael joined Sofinnova Partners in 2013 and is a partner in the Industrial Biotech Strategy. His primary focus is on identifying early-stage deals in Europe and North America with applications ranging from chemicals, materials, agriculture, food, feed, and synthetic biology.

In addition to being a board member of Afyren, Michael is or has been on the board of directors of Elicit Plant, Meiogenix, EnginZyme, Comet Bio, and EnobraQ. He also served for 2 years as the CEO of EnobraQ, a Sofinnova Partners’ Green Seed Fund portfolio company.

Before joining Sofinnova, Michael...Read more

Frank is the Managing Director of DuPont Ventures (Concurrent with Director of Licensing) in the areas of Nutrition & Health, Industrial Bio Sciences, Electronics & Imaging, Safety & Construction, and Transportation & Advanced Polymers. He works closely with the DuPont businesses to capture new and strategic opportunities primarily in the Specialty Chemical areas (IoT, machine learning, biotech, food, beverage and supplements that address digestive, metabolic and cardiovascular health, as well as specialty food protection, electronics and imaging, and construction and...Read more

Dan currently serves as the Head of Open Innovation for Braskem’s Renewable Chemicals and Materials group. In this role, he and his team are responsible for accelerating the flow of new technologies into and through Braskem’s Renewables R&D pipeline via the identification and participation in mutually beneficial collaborations.Read more

Mechanical forces are important regulators of tissue development and regeneration. In the Boerckel laboratory, we seek to understand the mechanisms by which mechanical cues influence morphogenesis, growth, adaptation, and repair, and we study how these developmental programs can be recapitulated to engineer functional tissues. Dr. Boerckel completed his undergraduate studies in Mechanical Engineering at Grove City College, and received the PhD degree, also in Mechanical Engineering, from Georgia Tech in 2011. Following postdoctoral training in vascular biology at the Cleveland Clinic and a...Read more